We are live on ! Find out more
HWM

HighMark Wealth Management Portfolio holdings

AUM $246M
1-Year Est. Return 35.95%
This Fund
S&P 500
This Quarter Est. Return
+10.64%
1 Year Est. Return
+35.95%
3 Year Est. Return
+84.22%
5 Year Est. Return
+86.67%
10 Year Est. Return
–
AUM
$245M
AUM Growth
+$18.2M
Cap. Flow
+$2.74M
Cap. Flow %
1.12%
Top 10 Hldgs %
66.41%
Holding
667
New
60
Increased
182
Reduced
81
Closed
82

Top Buys

Rank Stock Value
1
AXGN icon
Axogen
AXGN
+$3.91M
2
SIBN icon
SI-BONE Inc
SIBN
+$2.35M
3
NEO icon
NeoGenomics
NEO
+$1.8M
4
MASS icon
908 Devices
MASS
+$1.68M
5
HCAT icon
Health Catalyst
HCAT
+$1.18M

Top Sells

Rank Stock Value
1
PHLT
Performant Healthcare Inc
PHLT
+$5.84M
2
ANAB icon
AnaptysBio
ANAB
+$1.6M
3
INSM icon
Insmed
INSM
+$1M
4
ATEC icon
Alphatec Holdings
ATEC
+$740K
5
WFC icon
Wells Fargo
WFC
+$539K

Sector Composition

Rank Sector Weight
1 Healthcare 22.08%
2 Financials 4.47%
3 Technology 3.55%
4 Industrials 1.31%
5 Consumer Discretionary 1.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CRBP icon
551
Corbus Pharmaceuticals
CRBP
$168M
$333 ﹤0.01%
41
– –
XLF icon
552
State Street Financial Select Sector SPDR ETF
XLF
$56.8B
$328 ﹤0.01%
+6
New +$320
BHF icon
553
Brighthouse Financial
BHF
$3.64B
$323 ﹤0.01%
5
– –
GEMI
554
Gemini Space Station
GEMI
$520M
$297 ﹤0.01%
30
– –
PLUG icon
555
Plug Power
PLUG
$2.92B
$295 ﹤0.01%
150
– –
BIL icon
556
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$47.1B
$289 ﹤0.01%
3
+2
+200% +$183
STZ icon
557
Constellation Brands
STZ
$22.3B
$285 ﹤0.01%
2
– –
STRO icon
558
Sutro Biopharma
STRO
$411M
$266 ﹤0.01%
23
– –
OSUR icon
559
OraSure Technologies
OSUR
$273M
$242 ﹤0.01%
100
– –
ULTA icon
560
Ulta Beauty
ULTA
$22.2B
– –
0
– –
QUCY
561
Quantum Cyber N.V.
QUCY
$25.3M
$224 ﹤0.01%
+200
New +$263
VMBS icon
562
Vanguard Mortgage-Backed Securities ETF
VMBS
$15.5B
$218 ﹤0.01%
5
– –
FDFF icon
563
Fidelity Disruptive Finance ETF
FDFF
$42.8M
$215 ﹤0.01%
6
– –
LUMN icon
564
Lumen
LUMN
$6.76B
$194 ﹤0.01%
25
– –
USIG icon
565
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
$17.3B
$186 ﹤0.01%
4
– –
VOD icon
566
Vodafone
VOD
$37.2B
$184 ﹤0.01%
14
– –
RH icon
567
RH
RH
$3.15B
$179 ﹤0.01%
1
– –
ZNTL icon
568
Zentalis Pharmaceuticals
ZNTL
$350M
$175 ﹤0.01%
130
– –
KD icon
569
Kyndryl
KD
$2.98B
$159 ﹤0.01%
6
– –
HRTX icon
570
Heron Therapeutics
HRTX
$94.1M
$130 ﹤0.01%
100
– –
FUBO icon
571
FuboTV Inc
FUBO
$253M
$126 ﹤0.01%
4
– –
TIP icon
572
iShares TIPS Bond ETF
TIP
$14.5B
$112 ﹤0.01%
1
– –
UAA icon
573
Under Armour
UAA
$2.91B
$104 ﹤0.01%
21
– –
UA icon
574
Under Armour Class C
UA
$2.85B
$100 ﹤0.01%
21
– –
ARAY icon
575
Accuray
ARAY
$33.9M
$82 ﹤0.01%
100
– –
21 22
23
24 25

Similar funds

IRP
Investment Research Partners Lemont, Pennsylvania $246M AUM
EPIM
Equinox Partners Investment Management Stamford, Connecticut $245M AUM 225.58% 1-Year Est. Return
MAMHA
MY.Alpha Management HK Advisors Hong Kong $246M AUM 73.75% 1-Year Est. Return
CSC
Caldwell Sutter Capital Sausalito, California $246M AUM 23.62% 1-Year Est. Return
NTCM
Nut Tree Capital Management New York $245M AUM 34.1% 1-Year Est. Return
VPA
Vernal Point Advisors San Francisco, California $246M AUM 12.97% 1-Year Est. Return
KC
Kinloch Capital Glen Allen, Virginia $245M AUM 18.26% 1-Year Est. Return
SVWG
Shared Vision Wealth Group Carlsbad, United States $245M AUM 15.52% 1-Year Est. Return

HighMark Wealth Management's Q4 2025 Portfolio in Review

As of Q4 2025, HighMark Wealth Management held 667 positions worth $245M, up 8% from $227M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

HighMark Wealth Management's Q4 2025 filing shows 60 new, 182 increased, 81 reduced and 82 closed positions. Its largest new stake was 908 Devices: 241,000 shares worth $1.27M. The largest sale was Performant Healthcare Inc, an estimated $5.84M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 18% a quarter earlier, followed by Financials and Technology.

  • HighMark Wealth Management's largest Q4 2025 buy was 908 Devices: 241,000 shares worth $1.27M.
  • HighMark Wealth Management added most to Axogen in Q4 2025, an estimated $3.91M increase.
  • HighMark Wealth Management's biggest Q4 2025 reduction was AnaptysBio, cutting an estimated $1.6M.
  • HighMark Wealth Management fully exited Performant Healthcare Inc in Q4 2025, selling an estimated $5.84M.
  • HighMark Wealth Management's ten largest holdings make up 66% of its $245M portfolio in Q4 2025.
  • HighMark Wealth Management opened 60 new positions and closed 82 in Q4 2025.
  • HighMark Wealth Management's portfolio value rose 8% quarter-over-quarter to $245M.

Based on HighMark Wealth Management's 13F filing for Q4 2025, filed 5 Feb 2026.